Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of the IL-2 Inducible Tcell Kinase in EBV-HLH and EBV+ Hodgkin's Lymphoma

NCT01490801 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT01490801
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01490801 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of the IL-2 Inducible Tcell Kinase in EBV-HLH and EBV+ Hodgkin's Lymphoma
Lead sponsor
Children's Oncology Group
Phase
Observational
Overall status
Completed
Start date
December 31, 2011
Completion date
May 31, 2016
Enrollment
50 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma, nonneoplastic condition